Effect of ramipril on the incidence of diabetes.

Effect of ramipril on the incidence of diabetes.

BACKGROUND: Previous studies have suggested that blockade of the renin-angiotensin system may prevent diabetes in people with cardiovascular disease or hypertension. METHODS: In a double-blind, randomized clinical trial with a 2-by-2 factorial design, we randomly assigned 5269 participants without...

Podrobná bibliografie
Hlavní autoři:	Bosch, J, Yusuf, S, Gerstein, H, Pogue, J, Sheridan, P, Dagenais, G, Diaz, R, Avezum, A, Lanas, F, Probstfield, J, Fodor, G, Holman, R
Médium:	Journal article
Jazyk:	English
Vydáno:	2006

Podobné jednotky

Incidence of diabetes following ramipril or rosiglitazone withdrawal
Autor: Holman, R, a další
Vydáno: (2011)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
Autor: Investigators, D
Vydáno: (2011)

Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.
Autor: Punthakee, Z, a další
Vydáno: (2012)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
Autor: Gerstein, H, a další
Vydáno: (2006)

A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
Autor: Navjot Kaur, a další
Vydáno: (2017-11-01)

Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
Autor: G. Gulli
Vydáno: (2013-05-01)

Ramipril induced pemphigoid vulgaris
Autor: Mirza MA, a další
Vydáno: (2018-09-01)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
Autor: Daniele Bosone, a další
Vydáno: (2016-09-01)

Ramipril therapy in acute myocardial infarction
Autor: V. A. Lusov, a další
Vydáno: (2008-10-01)

Ramipril poisoning rescued by naloxone and terlipressin
Autor: Samanta Samanta, a další
Vydáno: (2014-01-01)

The Degradation Product of Ramipril Is Potentially Carcinogenic, Genotoxic and Mutagenic
Autor: Katarzyna Regulska, a další
Vydáno: (2023-02-01)

Effect of ramipril on renal function in patients with intermittent claudication
Autor: Simon D Hobbs, a další
Vydáno: (2008-04-01)

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
Autor: Hertzel C. Gerstein, a další
Vydáno: (2022-08-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Autor: I. V. Szirov, a další
Vydáno: (2015-12-01)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
Autor: S. V. Nedogoda
Vydáno: (2016-09-01)

Development of Methods of Quality Control of the Tablets «Ramipril»
Autor: Kateryna Typlynska, a další
Vydáno: (2023-04-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
Autor: I. V. Szirov, a další
Vydáno: (2015-12-01)

V fokuse vnimaniya - ingibitoryangiotenzinprevrashchayushchegofermenta: ramipril priarterial'noy gipertonii
Autor: I E Chazova, a další
Vydáno: (2011-09-01)

Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial
Vydáno: (2008)

The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases
Autor: E. E. Averin, a další
Vydáno: (2019-01-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Autor: S. R. Willoughby, a další
Vydáno: (2015-12-01)

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
Autor: S. R. Willoughby, a další
Vydáno: (2015-12-01)

Comparison of the efficacy, safety and tolerability of ramipril with amlodipine in treatment of mild to moderate hypertension in Nigerians
Autor: B J C Onwubere, a další
Vydáno: (2007-01-01)

MARRIAGE: A Randomized Trial of Moxonidine Ramipril or in Combination With Ramipril in Overweight Patients With Hypertension and Impaired Fasting Glucose or Diabetes Mellitus. Impact on Blood Pressure, Heart Rate and Metabolic Parameters
Autor: Paul Valensi MD, a další
Vydáno: (2024-06-01)

Three-dimensional printing of ramipril tablets by fused deposition modeling
Autor: O. A. Terenteva, a další
Vydáno: (2021-12-01)

Effect of Valsartan on the Incidence of Diabetes REPLY
Autor: Holman, R, a další
Vydáno: (2010)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
Autor: I. E. Chazova, a další
Vydáno: (2010-08-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Autor: V. I. Podzolkov, a další
Vydáno: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
Autor: V. I. Podzolkov, a další
Vydáno: (2015-09-01)

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored.
Autor: McMurray, J, a další
Vydáno: (2014)

Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL Study (Diabete, Ipertensione, Albuminuria, Lercanidipina)
Autor: M. Dalla Vestra, a další
Vydáno: (1970-01-01)

RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
Autor: A. I. Chesnikova, a další
Vydáno: (2016-01-01)

Solid-State Stability Profiling of Ramipril to Optimize Its Quality Efficiency and Safety
Autor: Katarzyna Regulska, a další
Vydáno: (2021-10-01)

ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
Autor: M.A. Dolinnayä, a další
Vydáno: (2017-03-01)

CHANGES IN CLINICAL MANIFESTATION OF CONGESTIVE HEART FAILURE AT THE BACKGROUND OF REGULAR RAMIPRIL INTAKE
Autor: A. G. Kuzmin, a další
Vydáno: (2014-08-01)

Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine
Autor: M. V. Leonova
Vydáno: (2020-05-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Autor: D. A. Napalkov, a další
Vydáno: (2016-01-01)

DISSOLUTION PROFILE STUDIES FOR RAMIPRIL AND LERCANIDIPINE FIXED-DOSE COMBINATION
Autor: A. A. Shadrin, a další
Vydáno: (2019-01-01)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
Autor: Duygun Altıntaş Aykan, a další
Vydáno: (2020-10-01)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
Autor: D. A. Napalkov, a další
Vydáno: (2016-01-01)